These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23428067)

  • 21. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.
    Helft G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI; Prasad A; Lenkovsky F; Makary LF; Kandil ES; Weideman RA; Kelly KC; Rangan BV; Banerjee S; Brilakis ES
    EuroIntervention; 2013 Jun; 9(2):204-11. PubMed ID: 23454910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R; Rossini R; Musumeci G; Gadda F; Pozzo LF
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcomes of preoperative bridging therapy for patients undergoing surgery after coronary stent implantation: a weighted meta-analysis of 280 patients from eight studies.
    Warshauer J; Patel VG; Christopoulos G; Kotsia AP; Banerjee S; Brilakis ES
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):25-31. PubMed ID: 24740634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet Reactivity: Is There a Role to Switch?
    Aradi D; Merkely B; Komócsi A
    Prog Cardiovasc Dis; 2015; 58(3):278-84. PubMed ID: 26260612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent thrombosis: a clinical perspective.
    Claessen BE; Henriques JP; Jaffer FA; Mehran R; Piek JJ; Dangas GD
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1081-92. PubMed ID: 25341705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?
    Garratt KN
    Prog Cardiovasc Dis; 2015; 58(3):285-98. PubMed ID: 26343876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual antiplatelet therapy after drug-eluting stents: defining the proper duration.
    Park SJ; Kang SM; Park DW
    Coron Artery Dis; 2014 Jan; 25(1):83-9. PubMed ID: 24322887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
    Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY
    Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?
    Casella G; Resciniti E; Gallo P
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308
    [No Abstract]   [Full Text] [Related]  

  • 31. A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.
    Rossini R; Tarantini G; Musumeci G; Masiero G; Barbato E; Calabrò P; Capodanno D; Leonardi S; Lettino M; Limbruno U; Menozzi A; Marchese UOA; Saia F; Valgimigli M; Ageno W; Falanga A; Corcione A; Locatelli A; Montorsi M; Piazza D; Stella A; Bozzani A; Parolari A; Carone R; Angiolillo DJ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    JACC Cardiovasc Interv; 2018 Mar; 11(5):417-434. PubMed ID: 29519377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.
    Khan SU; Riaz IB; Rahman H; Lone AN; Raza M; Khan MS; Riaz A; Kaluski E
    Eur J Prev Cardiol; 2019 Mar; 26(4):429-432. PubMed ID: 30152256
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.
    Capodanno D; Angiolillo DJ
    JACC Cardiovasc Interv; 2017 Mar; 10(5):425-437. PubMed ID: 28279311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Antiplatelet Agents: The Current State and What Is Coming Down the Pike.
    Franchi F; Rollini F; Park Y; Angiolillo DJ
    Prog Cardiovasc Dis; 2015; 58(3):267-77. PubMed ID: 26277706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives.
    Albuquerque FN; Bortnick A; Iqbal J; Ishibashi Y; Stone GW; Serruys PW
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):909-19. PubMed ID: 26257287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Developments in percutaneous coronary intervention and coronary stents].
    Simsek C; Daemen J; Zijlstra F
    Ned Tijdschr Tandheelkd; 2014; 121(7-8):375-9. PubMed ID: 25174186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New directions in antiplatelet therapy.
    Ferreiro JL; Angiolillo DJ
    Circ Cardiovasc Interv; 2012 Jun; 5(3):433-45. PubMed ID: 22715450
    [No Abstract]   [Full Text] [Related]  

  • 38. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of antiplatelet therapy resistance in cardiac surgery.
    Gasparovic H; Petricevic M; Biocina B
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):855-62. PubMed ID: 24332669
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.